USA – FDA, CDC recommend J&J vaccine pause while rare clots investigated

In a joint statement followed by a Tuesday morning press conference, the US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have recommended that administration of the one-dose Johnson & Johnson COVID-19 vaccine be paused.
 
The recommendation follows reports of six US cases of women between the ages of 18 and 48 years who received the vaccine and then experienced cerebral venous sinus thrombosis (CVST) – a blood clot in a large vessel draining blood near the base of the brain – in combination with low blood platelet counts, or thrombocytopenia.
 
To date, one patient has died and another is critically ill following vaccination with the Johnson & Johnson vaccine, develop by Janssen, the firm’s vaccines unit. The cases occurred between 6 and 13 days after receiving the Johnson & Johnson human adenovirus vector vaccine. Approximately 7 million doses of the Johnson & Johnson vaccine have been administered in the US…